Document is current
Any future updates will be listed below
-
Authors
Xue, Weiguang
Valderrama, Adriana
Ramakrishnan, Karthik
Zhou, Jenny
Meng, Yan
Bordia, Sonal
Shah, Manish A.
-
Funding
Funding for this research was provided by:
Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA
- License Information
-
More Information
Article History
Received: 25 July 2025
Accepted: 23 March 2026
First Online: 10 April 2026
Declarations
:
: Not applicable.
: Not applicable.
: A.V. is an employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, and a stockholder of Merck & Co., Inc., Rahway, NJ, USA .S.B. is an employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, and a stockholder of Merck & Co., Inc., Rahway, NJ, USA. At the time of this study, K.R. was an employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, and a stockholder of Merck & Co., Inc., Rahway, NJ, USA.J.Z. is an employee of Analysis Group, a consulting company that has provided paid consulting services to Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.W.X. is an employee of Analysis Group, a consulting company that has provided paid consulting services to Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. Y.M. is an employee of Analysis Group, a consulting company that has provided paid consulting services to Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.M.A.S. is a professor at Weill Cornell Medicine and has received research funding from Merck, Bristol-Myers Squibb, and Oncolys BioPharma.
